Tag Archives: ACR

October, 2018

November, 2016

July, 2016

March, 2016

January, 2016

  • 11 January

    Baxalta and Coherus’ Enbrel Biosimilar Meets Primary Endpoint in Late-Stage Study

    REDWOOD CITY, Calif., and BANNOCKBURN, Ill., Jan. 11, 2016 (GLOBE NEWSWIRE) — Coherus BioSciences, Inc. (NASDAQ:CHRS) and Baxalta Incorporated (NYSE:BXLT) today announced that CHS-0214, a proposed biosimilar of Enbrel® (etanercept), met its primary endpoint in a confirmatory, double-blind, randomized, controlled, two-part clinical study. This ongoing study is evaluating the efficacy and safety of CHS-0214 compared to Enbrel in patients …

April, 2015